Records from December 5, 2025 indicate that Representative David Taylor of Ohio made a sale of Amgen (NASDAQ: AMGN ), valued ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

On December 3, BMO Capital’s Evan Seigerman increased the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $372 from $335 ...

Amgen’s AMGN stock has risen almost 16% in a month. A lot of this price increase is due to strong third-quarter 2025 results, ...

Amgen (AMGN) shares soared 3.5% in the last trading session to close at $285.41. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Amgen Inc. (NASDAQ:AMGN) ranks among the Best Low Volatility Investments in December 2025. Goldman Sachs reaffirmed its $400 ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more ...

Amgen (NASDAQ: AMGN) has outperformed the market over the past 15 years by 1.0% on an annualized basis producing an average annual return of 13.12%. Currently, Amgen has a market capitalization of ...

Though Amgen AMGN and Viking Therapeutics VKTX do not currently market any obesity drugs, they are among the few biotechs that have shown immense potential in this space. Amgen boasts a strong ...